The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Molecular mechanism of VEGF and its role in pathological angiogenesis
Abstract
Over the last seven decades, a significant scientific contribution took place in the delineation of the implications of vascular endothelial‐derived growth factor (VEGF) in the processes of angiogenesis. Under pathological conditions, mainly in response to hypoxia or ischemia, elevated VEGF levels promote vascular damage and the growth of abnormal blood vessels. Indeed, the development of VEGF biology has revolutionized our understanding of its role in pathological conditions. Hence, targeting VEGF or VEGF‐mediated molecular pathways could be an excellent therapeutic strategy for managing cancers and intraocular neovascular disorders. Although anti‐VEGF therapies, such as monoclonal antibodies and small‐molecule tyrosine kinase inhibitors, have limited clinical efficacy, they can still significantly improve the overall survival rate. This thus demands further investigation through the development of alternative strategies in the management of VEGF‐mediated pathological angiogenesis. This review article focuses on the recent developments toward the delineation of the functional biology of VEGF and the role of anti‐VEGF strategies in the management of tumor and eye pathologies. Moreover, therapeutic angiogenesis, an exciting frontier for the treatment of ischemic disorders, is highlighted in this review, including wound healing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
[WITHDRAWN] Retinal Vasculature in Development and Diseases
Sun, Y., & Smith, L. E. H. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034018 · Cited by 109
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Factors affecting wound healing
Guo, S., & DiPietro, L. A. (2010) · Journal of Dental Research · doi:10.1177/0022034509359125 · Cited by 5,792
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Grothey, A., Cutsem, E. V., Sobrero, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61900-x · Cited by 2,895
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Mintz-Hittner, H. A., Kennedy, K. A., & Chuang, A. Z. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007374 · Cited by 1,455
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Gong, J., Chehrazi-Raffle, A., Reddi, S., & Salgia, R. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0316-z · Cited by 1,273
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
The Role of Vascular Endothelial Growth Factor in Wound Healing
Bao, P., Kodra, A., Tomic-Canic, M., Golinko, M. S., Ehrlich, H. P., & Brem, H. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.04.023 · Cited by 1,211
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L. D., Newbold, K., Papotti, M. G., & Berruti, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz400 · Cited by 1,200
Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., & Kerbel, R. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8829 · Cited by 1,168
Kim, S.-H., Turnbull, J., & Guimond, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0377 · Cited by 1,166
Garcia, J., Hurwitz, H. I., Sandler, A. B., Miles, D., Coleman, R. L., Deurloo, R., & Chinot, O. L. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102017 · Cited by 1,159
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Mechanisms of adverse effects of anti-VEGF therapy for cancer
Kamba, T., & McDonald, D. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603813 · Cited by 990
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Gerber, H.-P., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 981
Antiangiogenic therapy in oncology: current status and future directions
Jayson, G. C., Kerbel, R., Ellis, L. M., & Harris, A. L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01088-0 · Cited by 828
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Galiano, R. D., Tepper, O. M., Pelo, C. R., Bhatt, K. A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H. G., & Gurtner, G. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63754-6 · Cited by 798
Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross, J. G., Glassman, A. R., Jampol, L. M., Inusah, S., Aiello, L. P., Antoszyk, A. N., Baker, C. W., Berger, B. B., Bressler, N. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.15217 · Cited by 784
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
Frank, S., Hübner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., & Werner, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12607 · Cited by 764
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Takahashi, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2768 · Cited by 749
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E. K., Gekkieva, M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0493 · Cited by 720
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
Gerber, H.-P., Malik, A. K., Solar, G. P., Sherman, D., Liang, X. H., Meng, G., Hong, K., Marsters, J. C., & Ferrara, N. (2002) · Nature · doi:10.1038/nature00821 · Cited by 706
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677
MICHELS, S., ROSENFELD, P., PULIAFITO, C., MARCUS, E., & VENKATRAMAN, A. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.02.007 · Cited by 664
Targeting VEGF/VEGFR to modulate antitumor immunity
Yang, J., Yan, J., & Liu, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00978 · Cited by 646
Angiogenesis and wound repair: when enough is enough
DiPietro, L. A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0316-102r · Cited by 641
Knighton, D. R., Silver, I. A., & Hunt, T. K. (1981) · PubMed · Cited by 633
Abnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Gerber, H.-P., & Ferrara, N. (2005) · Cancer Research · doi:10.1158/0008-5472.671.65.3 · Cited by 626
Intravitreal Aflibercept for Diabetic Macular Edema
Brown, D. M., Schmidt-Erfurth, U., Do, D. V., Holz, F. G., Boyer, D. S., Midena, E., Heier, J. S., Terasaki, H., Kaiser, P. K., Marcus, D. M., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.06.017 · Cited by 623
The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
Wong, T., Chakravarthy, U., Klein, R., Mitchell, P., Zlateva, G., Buggage, R., Fahrbach, K., Probst, C., & Sledge, I. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.008 · Cited by 601
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
Poon, R. T.-P., Fan, S.-T., & Wong, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1207 · Cited by 587
Hellstrom, A., Perruzzi, C., Ju, M., Engström, E., Hård, A.-L., Liu, J.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Sjödell, L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101113998 · Cited by 583
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Properties of FDA-approved small molecule protein kinase inhibitors
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.006 · Cited by 554
(2002) · PubMed · Cited by 550
Brogi, E., Wu, T., Namiki, A., & Isner, J. M. (1994) · Circulation · doi:10.1161/01.cir.90.2.649 · Cited by 546
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.016 · Cited by 532
VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix
Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., & Neufeld, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7151 · Cited by 519
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Pottier, C., Fresnais, M., Gilon, M., Jérusalem, G., Longuespée, R., & Sounni, N. E. (2020) · Cancers · doi:10.3390/cancers12030731 · Cited by 515
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Teleanu, R. I., Chircov, C., Grumezescu, A. M., & Teleanu, D. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010084 · Cited by 503
Plouët, J., Schilling, J., & Gospodarowicz, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08557.x · Cited by 492
Algire, G. H., Chalkley, H. W., Legallais, F. Y., & Park, H. D. (1945) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/6.1.73 · Cited by 472
Adnane, L., Trail, P. A., Taylor, I., & Wilhelm, S. M. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(05)07047-3 · Cited by 463
Järbrink, K., Ni, G., Sönnergren, H., Schmidtchen, A., Pang, C., Bajpai, R., & Car, J. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0329-y · Cited by 454
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
Grossniklaus, H. E., Ling, J. X., Wallace, T. M., Dithmar, S., Lawson, D., Cohen, C., Elner, V. M., Elner, S. G., & Sternberg, P. (2002) · PubMed · Cited by 434
Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A., & Ferrara, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115568 · Cited by 433
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F., & Ziche, M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.1.h411 · Cited by 417
Regulation of vascular permeability by vascular endothelial growth factors
Bates, D. O., & Harper, S. J. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00011-9 · Cited by 411
Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., & Fujisawa, H. (1995) · Development · doi:10.1242/dev.121.12.4309 · Cited by 410
Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Do, D. V., Nguyen, Q. D., Boyer, D., Schmidt-Erfurth, U., Brown, D. M., Vitti, R., Berliner, A. J., Gao, B., Zeitz, O., Ruckert, R., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.010 · Cited by 385
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
VEGF-A Induces Expression of eNOS and iNOS in Endothelial Cells via VEGF Receptor-2 (KDR)
Kroll, J., & Waltenberger, J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9719 · Cited by 367
FRANK, R. N., AMIN, R. H., ELIOTT, D., PUKLIN, J. E., & ABRAMS, G. W. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)72066-5 · Cited by 366
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Sitohy, B., Nagy, J. A., & Dvorak, H. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3406 · Cited by 360
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1996) · PubMed · Cited by 332
“Sprouting angiogenesis”, a reappraisal
Ribatti, D., & Crivellato, E. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.09.018 · Cited by 325
Regulation of scar formation by vascular endothelial growth factor
Wilgus, T. A., Ferreira, A. M., Oberyszyn, T. M., Bergdall, V. K., & DiPietro, L. A. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.36 · Cited by 319
Brekken, R. A., Overholser, J. P., Stastny, V., Waltenberger, J. L., Minna, J. D., & Thorpe, P. E. (2000) · PubMed · Cited by 307
Peptide-based cancer therapy: Opportunity and challenge
Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., & Li, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.002 · Cited by 306
Receptor Tyrosine Kinase-Targeted Cancer Therapy
Yamaoka, T., Kusumoto, S., Ando, K., Ohba, M., & Ohmori, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113491 · Cited by 297
Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation
DeLeve, L. D., Wang, X., Hu, L., McCuskey, M. K., & McCuskey, R. S. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2004 · Cited by 296
Pathogenesis of retinopathy of prematurity
Smith, L. E. H. (2003) · Seminars in Neonatology · doi:10.1016/s1084-2756(03)00119-2 · Cited by 295
VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis
Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P., Wang, L., Wikner, C., Qi, J. H., Wernstedt, C., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600709 · Cited by 292
Horowitz, J. R., Rivard, A., van der Zee, R., Hariawala, M., Sheriff, D. D., Esakof, D. D., Chaudhry, G. M., Symes, J. F., & Isner, J. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2793 · Cited by 266
Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins
Herzog, Y., Kalcheim, C., Kahane, N., Reshef, R., & Neufeld, G. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00518-4 · Cited by 264
Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration
D’Amico, D. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.027 · Cited by 260
Angiogenesis and Its Therapeutic Opportunities
Yoo, S. Y., & Kwon, S. M. (2013) · Mediators of Inflammation · doi:10.1155/2013/127170 · Cited by 259
Ferrara, N. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-07-0590 · Cited by 251
Le Tourneau, C., Raymond, E., & Faivre, S. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.2.341 · Cited by 247
Lee, J.-H., Canny, M. D., De Erkenez, A., Krilleke, D., Ng, Y.-S., Shima, D. T., Pardi, A., & Jucker, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509069102 · Cited by 242
Vascular endothelial growth factor and diabetic complications
WIROSTKO, B., WONG, T., & SIMO, R. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.09.002 · Cited by 241
Hutchings, H., Ortega, N., & Plouët, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0691fje · Cited by 235
Ide, A. (1939) · American Journal of Roentgenology · Cited by 234
Kondo, T., Vicent, D., Suzuma, K., Yanagisawa, M., King, G. L., Holzenberger, M., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17455 · Cited by 228
Schwesinger, C., Yee, C., Rohan, R. M., Joussen, A. M., Fernandez, A., Meyer, T. N., Poulaki, V., Ma, J. J. K., Redmond, T. M., Liu, S., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64063-1 · Cited by 225
The Role of Neuropilin in Vascular and Tumor Biology
Klagsbrun, M., Takashima, S., & Mamluk, R. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0119-0_3 · Cited by 220
Perrin, R. M., Konopatskaya, O., Qiu, Y., Harper, S., Bates, D. O., & Churchill, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1951-8 · Cited by 217
Molecular Mechanisms of Tumor Angiogenesis
Ziyad, S., & Iruela-Arispe, M. L. (2011) · Genes & Cancer · doi:10.1177/1947601911432334 · Cited by 215
Ross, E. L., Hutton, D. W., Stein, J. D., Bressler, N. M., Jampol, L. M., Glassman, A. R., & for the Diabetic Retinopathy Clinical Research Network (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.1669 · Cited by 209
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
Kieran, M. W., Kalluri, R., & Cho, Y.-J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006593 · Cited by 206
Nawaz, I. M., Rezzola, S., Cancarini, A., Russo, A., Costagliola, C., Semeraro, F., & Presta, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.03.002 · Cited by 195
Howdieshell, T. R., Callaway, D., Webb, W. L., Gaines, M. D., Procter, C. D., Sathyanarayana, Pollock, J. S., Brock, T. L., & McNeil, P. L. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6089 · Cited by 188
Brem, H., Kodra, A., Golinko, M. S., Entero, H., Stojadinovic, O., Wang, V. M., Sheahan, C. M., Weinberg, A. D., Woo, S. L. C., Paul Ehrlich, H., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.26 · Cited by 182
Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165
Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., & Ron, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10816 · Cited by 182
The VEGF family in cancer and antibody-based strategies for their inhibition
Sullivan, L. A., & Brekken, R. A. (2010) · mAbs · doi:10.4161/mabs.2.2.11360 · Cited by 181
Berlin, J., Bendell, J. C., Hart, L. L., Firdaus, I., Gore, I., Hermann, R. C., Mulcahy, M. F., Zalupski, M. M., Mackey, H. M., Yauch, R. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1800 · Cited by 181
Lamalice, L., Houle, F., & Huot, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603928200 · Cited by 177
Seddon, J. M., George, S., Rosner, B., & Klein, M. L. (2006) · Human Heredity · doi:10.1159/000094141 · Cited by 176
Therapeutic targets in age-related macular disease
Bird, A. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42437 · Cited by 175
Schnell, C. R., Stauffer, F., Allegrini, P. R., O'Reilly, T., McSheehy, P. M. J., Dartois, C., Stumm, M., Cozens, R., Littlewood-Evans, A., García-Echeverría, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1044 · Cited by 174
Pathological angiogenesis and inflammation in tissues
Jeong, J.-H., Ojha, U., & Lee, Y. M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01287-2 · Cited by 174
Sultan, M. B., Zhou, D., Loftus, J., Dombi, T., & Ice, K. S. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.045 · Cited by 172
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
Ola, M. S., Nawaz, M. I., Siddiquei, M. M., Al-Amro, S., & Abu El-Asrar, A. M. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.11.004 · Cited by 170
Self-citationGaleano, M., Deodato, B., Altavilla, D., Cucinotta, D., Arsic, N., Marini, H. R., Torre, V., Giacca, M., & Squadrito, F. (2003) · Diabetologia · doi:10.1007/s00125-003-1064-1 · Cited by 157
Tumor Neovascularization and Developments in Therapeutics
Katayama, Y., Uchino, J., Chihara, Y., Tamiya, N., Kaneko, Y., Yamada, T., & Takayama, K. (2019) · Cancers · doi:10.3390/cancers11030316 · Cited by 153
Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
Qayum, N., Muschel, R. J., Im, J. H., Balathasan, L., Koch, C. J., Patel, S. K., McKenna, W. G., & Bernhard, E. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0657 · Cited by 151
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Zoeller, J. J., Whitelock, J. M., & Iozzo, R. V. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.04.010 · Cited by 143
Aflibercept for neovascular age-related macular degeneration
Sarwar, S., Clearfield, E., Soliman, M. K., Sadiq, M. A., Baldwin, A. J., Hanout, M., Agarwal, A., Sepah, Y. J., Do, D. V., & Nguyen, Q. D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011346.pub2 · Cited by 142
Sönmez, K., Drenser, K. A., Capone, A., & Trese, M. T. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.08.050 · Cited by 140
Chen, Q., Liu, Y., Jeong, H., Stehling, M., Dinh, V. V., Zhou, B., & Adams, R. H. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.10.006 · Cited by 140
Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor
Sun, F., & Guo, X. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20321 · Cited by 137
Inflammatory Complications of Intravitreal Anti-VEGF Injections
Cox, J. T., Eliott, D., & Sobrin, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050981 · Cited by 134
Baffi, J., Byrnes, G., Chan, C. –., & Csaky, K. G. (2000) · PubMed · Cited by 130
Bootle-Wilbraham, C. A., Tazzyman, S. J., Thompson, W. D., Stirk, C. M., & Lewis, C. E. (2001) · Angiogenesis · doi:10.1023/a:1016076121918 · Cited by 126
VRAP Is an Adaptor Protein That Binds KDR, a Receptor for Vascular Endothelial Cell Growth Factor
Wu, L., Mayo, L. D., Dunbar, J. D., Kessler, K. M., Özeş, O. N., Warren, R. S., & Donner, D. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6059 · Cited by 123
van Asten, F., Michels, C. T. J., Hoyng, C. B., van der Wilt, G. J., Klevering, B. J., Rovers, M. M., & Grutters, J. P. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197670 · Cited by 123
Li, Y., Hazarika, S., Xie, D., Pippen, A. M., Kontos, C. D., & Annex, B. H. (2007) · Diabetes · doi:10.2337/db06-0999 · Cited by 119
Signal transduction by vascular endothelial growth factor receptors
Claesson, L. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310020 · Cited by 118
Sun, N., Ning, B., Hansson, K. M., Bruce, A. C., Seaman, S. A., Zhang, C., Rikard, S. M., DeRosa, C. A., Fraser, C. L., Wågberg, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35570-6 · Cited by 118
Mole, D. R., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · IUBMB Life · doi:10.1080/15216540252774757 · Cited by 117
Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases
Seah, I. Y. J., Zhao, X., Lin, Q., Liu, Z., Su, S. Z. Z., Yuen, Y. S., Hunziker, W., Gopal, L., Loh, X. J., & Su, X. (2020) · Eye · doi:10.1038/s41433-020-0770-y · Cited by 115
Guyer, D. R. (1986) · Archives of Ophthalmology · doi:10.1001/archopht.1986.01050170092029 · Cited by 113
Animal models of oxygen-induced retinopathy
Penn, J. S. (2003) · Frontiers in bioscience · doi:10.2741/1056 · Cited by 111
Novel therapeutic targets in diabetic macular edema: Beyond VEGF
Urias, E. A., Urias, G. A., Monickaraj, F., McGuire, P. G., & Das, A. (2017) · Vision Research · doi:10.1016/j.visres.2017.06.015 · Cited by 104
Pathogenesis and Classification of Proliferative Diabetic Vitreoretinopathy
Kroll, P. B., Rodrigues, E. B., & Hoerle, S. (2007) · Ophthalmologica · doi:10.1159/000098253 · Cited by 99
Weekes, C., Beeram, M., Tolcher, A., Papadopoulos, K., Gore, L., Hegde, P., Xin, Y., Yu, R., Shih, L., Xiang, H., et al. (2014) · Investigational new drugs · doi:10.1007/s10637-014-0071-z · Cited by 99
Aflibercept—a Decoy VEGF Receptor
Ciombor, K. K., & Berlin, J. D. (2014) · Current Oncology Reports · doi:10.1007/s11912-013-0368-7 · Cited by 97
Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?
Montero, A. J., Escobar, M., Lopes, G. D. L., Jr., Glück, S., & Vogel, C. L. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0202-z · Cited by 89
Wang, F., Rendahl, K. G., Manning, W. C., Quiroz, D., Coyne, M. Y., & Miller, S. S. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0281 · Cited by 88
The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer
Qu, J., Mei, Q., Liu, L., Cheng, T., Wang, P., Chen, L., & Zhou, J. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835921992968 · Cited by 82
Hainsworth, J. D., Spigel, D. R., Sosman, J. A., Burris, H. A., Farley, C., Cucullu, H., Yost, K., Hart, L. L., Sylvester, L., Waterhouse, D. M., et al. (2007) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2007.n.030 · Cited by 80
Therapeutic Approaches to the Regulation of Wound Angiogenesis
Wietecha, M. S., & DiPietro, L. A. (2013) · Advances in Wound Care · doi:10.1089/wound.2011.0348 · Cited by 79
A perspective on the role of class III semaphorin signaling in central nervous system trauma
Mecollari, V., Nieuwenhuis, B., & Verhaagen, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00328 · Cited by 79
Teran, M., & Nugent, M. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627372 · Cited by 77
Heparan sulfate in angiogenesis: a target for therapy
van Wijk, X. M. R., & Kuppevelt, T. H. V. (2013) · Angiogenesis · doi:10.1007/s10456-013-9401-6 · Cited by 74
Stephan, S., Datta, K., Wang, E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0808 · Cited by 74
Kim, A., Balis, F. M., & Widemann, B. C. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0088 · Cited by 73
Savorè, C., Zhang, C., Muir, C., et al. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2339-3 · Cited by 71
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
Moyal, E. C., Evans, S. M., Koch, C. J., Muschel, R. J., McKenna, W. G., Wu, J., & Bernhard, E. J. (2001) · PubMed · Cited by 70
Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Su, C., Wang, H., Liu, Y., Guo, Q., Zhang, L., Li, J., Zhou, W., Yan, Y., Zhou, X., & Zhang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.554313 · Cited by 69
Yuen, W. W., Du, N. R., Chan, C. H., Silva, E. A., & Mooney, D. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001192107 · Cited by 67
Regional differences in the global burden of age-related macular degeneration
Xu, X., Wu, J., Yu, X., Tang, Y., Tang, X., & Shentu, X. (2020) · BMC Public Health · doi:10.1186/s12889-020-8445-y · Cited by 67
Galeano, M., Deodato, B., Altavilla, D., Squadrito, G., Seminara, P., Marini, H. R., d’Alcontres, F. S., Colonna, M. R., Calò, M., Cascio, P. L., et al. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000059435.88283.c2 · Cited by 62
Hypoxia and VEGF mRNA Expression in Human Tumors
Ziemer, L. S., Koch, C. J., Maity, A. M., Magarelli, D. P., Horan, A. D., & Evans, S. M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900195 · Cited by 60
Pegaptanib sodium for the treatment of neovascular age-related macular degeneration
Moshfeghi, A. A., & Puliafito, C. A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.671 · Cited by 58
Dervenis, N., Mikropoulou, A. M., Tranos, P., & Dervenis, P. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0548-1 · Cited by 58
Shields, C. L. (2009) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(09)79093-8 · Cited by 56
Ramucirumab: preclinical research and clinical development
Aprile, G., Fontanella, C., Rihawi, K., Grossi, F., & Rijavec, E. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s61132 · Cited by 53
Refolo, M. G., Lotesoriere, C., Lolli, I. R., Messa, C., & D’Alessandro, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-64195-x · Cited by 53
Rezzola, S., Corsini, M., Chiodelli, P., Cancarini, A., Nawaz, M. I., Coltrini, D., Mitola, S. M. F., Ronca, R., Belleri, M., Lista, L., et al. (2017) · Diabetologia · doi:10.1007/s00125-016-4204-0 · Cited by 45
Self-citationWakelee, H. A., Zvirbule, Z., de Braud, F., Kingsley, C. D., Mekhail, T. M., Lowe, T., Schütte, W., Léna, H., Lawler, W. E., Braiteh, F., et al. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.09.013 · Cited by 43
Kendrew, J., Eberlein, C., Hedberg, B., McDaid, K., Smith, N. R., Weir, H. M., Wedge, S. R., Blakey, D. C., Foltz, I. N., Zhou, J. Q., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0876 · Cited by 33
García‐Carbonero, R., Cutsem, E. V., Rivera, F., Jassem, J., Gore, I., Tebbutt, N. C., Braiteh, F., Argilés, G., Wainberg, Z. A., Funke, R. P., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0133 · Cited by 30
Nawaz, M. I., Chiodelli, P., Rezzola, S., Paganini, G., Corsini, M., Lodola, A., Ianni, A. D., Mor, M., & Presta, M. (2017) · Angiogenesis · doi:10.1007/s10456-017-9581-6 · Cited by 30
Self-citationRezzola, S., Monte, M. D., Belleri, M., Bugatti, A., Chiodelli, P., Corsini, M., Cammalleri, M., Cancarini, A., Morbidelli, L., Oreste, P., et al. (2015) · Diabetes · doi:10.2337/db14-1378 · Cited by 24
Naderi, S., Roshan, R., Ghaderi, H., Behdani, M., Mahmoudi, S., Habibi‐Anbouhi, M., Shokrgozar, M. A., & Kazemi‐Lomedasht, F. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.10.004 · Cited by 19
Intravitreal Ziv-Aflibercept: A Comprehensive Review
Barmas-Alamdari, D., D’Souza, H. S., Kapoor, K., & Wagner, A. L. (2019) · Seminars in Ophthalmology · doi:10.1080/08820538.2019.1641526 · Cited by 18
Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab
Latzer, P., Schlegel, U. S., & Theiß, C. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12516 · Cited by 15
Nawaz, M. I., Rezzola, S., Tobia, C., Coltrini, D., Belleri, M., Mitola, S. M. F., Corsini, M., Sandomenico, A., Caporale, A., Ruvo, M., et al. (2020) · Angiogenesis · doi:10.1007/s10456-020-09714-0 · Cited by 15
Self-citationRezzola, S., Nawaz, M. I., Cancarini, A., Semeraro, F., & Presta, M. (2019) · Diabetes Care · doi:10.2337/dc18-2527 · Cited by 13
Self-citationKhosla, R., Rain, M., Chawathey, S., Modgil, S., Tyagi, R., Thakur, K., Pannu, V. S., Sharma, S., & Anand, A. (2020) · Muscle & Nerve · doi:10.1002/mus.27026 · Cited by 11
Seddon, J. M., George, S., ROSNER, B. A., & Klein, M. L. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.013 · Cited by 10
Metadata
- Authors
- Ahmad, A., & Nawaz, M. I.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2022-10-26
- Volume
- 123
- Issue
- 12
- Pages
- 1938-1965
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W4307431996
- Cited by
- 260
- References
- 188
- FWCI
- 13.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.